Sana Biotechnology, Inc. SANA
2.43 USD -0.03 (-1.42%)
At closeNov 11, 2026, 6:02 AM EST
2.40 -0.03 -1.23%
Pre-market · Nov 11, 6:02 AM ET
2.32 Day range 2.52
2.22 52-week range 5.49
- YTD
- -40.29%
- 1 year
- -42.69%
Financial health
Altman Z-Score
-6.10 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 2
Valuation
P/E -4.2×
FY 2018 5y median -2.8× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 6.4×
FY 2018 5y median 2.8× FY 2025
P/FCF -7.1×
FY 2018 5y median -2.9× FY 2025
EV/EBITDA -4.5×
FY 2018 5y median -3.0× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -14.0%
FY 2018 5y median -34.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -151.8%
FY 2018 5y median -98.5% FY 2025
ROIC -54.1%
FY 2018 5y median -54.1% FY 2025
ROA -58.6%
FY 2018 5y median -50.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 30.0%
FY 2018 FY 2025
EPS (diluted) 17.2%
FY 2018 FY 2025
Free Cash Flow 43.6%
FY 2018 FY 2025
Financial Health
Current Ratio 1.9×
FY 2018 5y median 3.5× FY 2025
Quick Ratio 1.9×
FY 2018 5y median 3.5× FY 2025
Debt / Equity 0.5×
FY 2018 5y median 0.4× FY 2025
Net Debt / EBITDA -0.0×
FY 2018 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31